Bank of America Corporation Discloses $1.2 Million in Latest Lobbying Efforts

Published On: April 19, 2025 6:04 am

Bank of America Discloses $1.2 Million in Q1 2025 Lobbying Expenses

Bank of America Corporation revealed $1,200,000 in lobbying expenditures for the first quarter of 2025 in a recent Lobbying Disclosure Act report.

Key Lobbying Issues

The bank’s lobbying effort focused on several critical regulatory topics, including:

S. 875, Financial Integrity and Regulation Management (FIRM) Act; Provisions related to supervision.
Anti-Money Laundering (AML) reforms.
Fair Access and the Credit Card Competition Act.
CFPB overdraft rulemaking and the Credit Card late fees rulemaking.
CFPB 1033 rule.
Federal Reserve discount window matters.
The Electronic Funds Transfer Act.
International tax reforms and IRA tax incentives.
S. 394, Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act of 2025; Provisions related to digital assets and stablecoins.
H.R. 2392, Stablecoin Transparency and Accountability for a Better Ledger Economy (STABLE) Act of 2025; Provisions related to digital assets and stablecoins.
SEC regulatory proposals regarding market structure.
Reauthorization of the Cybersecurity Information Sharing Act.
SEC’s Cyber Incident Disclosure Rule.

For further information on corporate lobbying, visit Quiver Quantitative.

Congressional Trading of BAC Stock

In the past six months, members of Congress have made two transactions involving Bank of America stock ($BAC), with one purchase and one sale recorded.

This breakdown details the trading activities of $BAC stock by members of Congress over that time:

To monitor congressional stock trading activities, explore Quiver Quantitative’s congressional trading dashboard.

Recent Hedge Fund Movements in BAC Stock

During the most recent quarter, 1,338 institutional investors increased their holdings in BAC stock, while 1,413 reduced theirs.

Here are some of the most significant recent changes:

BERKSHIRE HATHAWAY INC decreased its stake by 117,449,720 shares (-14.7%) in Q4 2024, representing an estimated $5,161,915,194.
DODGE & COX cut 22,147,719 shares (-41.6%) from its portfolio in Q4 2024, totaling approximately $973,392,250.
JPMORGAN CHASE & CO increased its position by 20,479,708 shares (+13.7%) in Q4 2024, valued at around $900,083,166.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP reduced shares by 19,653,417 (-66.5%) in Q4 2024, amounting to roughly $863,767,677.
BLACKROCK, INC. added 18,853,021 shares (+3.7%) in Q4 2024, valued at about $828,590,272.
WELLINGTON MANAGEMENT GROUP LLP increased by 18,705,125 shares (+39.6%) in Q4 2024, valued at an estimated $822,090,243.
CAPITAL WORLD INVESTORS raised its stake by 17,031,143 shares (+23.9%) in Q4 2024, worth approximately $748,518,734.

For details on hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.

Analyst Ratings for BAC

In recent months, Wall Street analysts have provided insights on Bank of America’s stock. Seven firms have assigned buy ratings, while none have issued sell ratings.

Recent analyst ratings include:

UBS rated it “Buy” on 04/16/2025.
Morgan Stanley rated it “Overweight” on 04/07/2025.
Oppenheimer rated it “Outperform” on 01/03/2025.
Wolfe Research rated it “Outperform” on 01/03/2025.
Evercore ISI rated it “Outperform” on 01/02/2025.
Citigroup rated it “Buy” on 12/24/2024.
Wells Fargo rated it “Overweight” on 10/30/2024.

For more information on analyst ratings and price targets for BAC, refer to Quiver Quantitative’s $BAC forecast page.

Price Targets for BAC

Recently, multiple analysts have set price targets for BAC. Over the last six months, four analysts have established a median price target of $52.0.

Here are some notable recent price targets:

Stephen Biggar from Argus Research set a target price of $47.0 on 04/16/2025.
An analyst from Robert W. Baird assigned a price target of $50.0 on 03/07/2025.
Betsy Graseck from Morgan Stanley set a target price of $54.0 on 01/07/2025.
Chris Kotowski from Oppenheimer established a target price of $54.0 on 01/03/2025.

This article is not financial advice. For further details, refer to Quiver Quantitative’s disclaimers.

This article was originally published on Quiver News; read the full story.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.